ARCHIVES

Amgen Agrees to Settle Aranesp Marketing Lawsuit, Reserves $780 Million For Settlement

This article is from The Cancer Letter archive.

Vol. 37 No. 40 | October 28, 2011

Download PDF Visit The Full Archive

Related Articles

Phase 0 Trials Signal FDA’s New Reliance On Biomarkers For Drug Development.

January 13, 2006

Enck New ACCC President, King President Elect

March 20, 1987

NIH Spent $181.3 Million on PR Last Year; House Probe Prompts Analysis of Spending

July 12, 2013

Dismissed Leukemia Drug Helps CLL, Clinical Trials Find

December 26, 2008

Tempero, Johnson Take ASCO Offices

June 6, 2003

Also in this 8-page issue: NCI, FDA open Web site for adverse event reporting.

April 16, 2004